← All stocks

IGC Pharma, Inc.

IGC Net selling

CIK 0001326205 #4916 in the set updated 21 Sep 2026

Bought (120 mo)

$200.00K

out of their own pocket, the only kind of buying there is

Sold (120 mo)

$1.44M

$0.00 on a plan · $0.00 straight out of an exercise

Sold at will

$1.44M

37 of 37 sales

Net

−$1.24M

−$1.24M against sales at will

By person

9 insiders · 40 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Mukunda Ram

CEO

—

$804.20K (22)

−$804.20K

8,563,731

8.28%

$2.91M

+8,218%

PRINS RICHARD K

Director

—

$347.27K (13)

−$347.27K

1,541,251

1.49%

$524.03K

—

GRIMALDI CLAUDIA

PFO

—

$287.04K (2)

−$287.04K

3,421,092

3.31%

$1.16M

+2,613%

Moran James P

Director

$200.00K (1)

—

+$200.00K

2,178,137

2.11%

$740.57K

+116.6%

Bradbury Strategic Investment Fund A (Cayman Islands Registration No. CR-359857) entity

10% owner

—

13,823,529

13.37%

$4.70M

+176.5%

SHENOY SUDHAKAR V

Director

—

695,000

0.6723%

$236.30K

+71.6%

Cherin John

CFO, Treasurer and PAO

—

325,000

0.3144%

$110.50K

+162.2%

GOEL ROHIT

Senior Director of Finance&PAO

—

235,000

0.2273%

$79.90K

+135.0%

LYNCH John Edward

Director

—

134,401

0.1300%

$45.70K

+38.7%

Individual transactions

Insider

Date

Role

Action

Price

Amount

Moran James P

25 Sep 2024

Director

Buy indirect

588,235

$0.34

$200.00K

Show all 40 transactions →

What was left out

Form 4 filings counted 71

Amendments (4/A) skipped 1

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 0

Sales at will 37

Transactions with no price 0

Shares from compensation/vesting 30,179,597

Sales filed before the plan box existed 37

History held since 20 Dec 2016